1. Home
  2. VNDA vs TCMD Comparison

VNDA vs TCMD Comparison

Compare VNDA & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • TCMD
  • Stock Information
  • Founded
  • VNDA N/A
  • TCMD 1995
  • Country
  • VNDA United States
  • TCMD United States
  • Employees
  • VNDA N/A
  • TCMD N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • TCMD Medical/Dental Instruments
  • Sector
  • VNDA Health Care
  • TCMD Health Care
  • Exchange
  • VNDA Nasdaq
  • TCMD Nasdaq
  • Market Cap
  • VNDA 362.6M
  • TCMD 273.3M
  • IPO Year
  • VNDA 2006
  • TCMD 2016
  • Fundamental
  • Price
  • VNDA $6.34
  • TCMD $12.68
  • Analyst Decision
  • VNDA Buy
  • TCMD Buy
  • Analyst Count
  • VNDA 1
  • TCMD 1
  • Target Price
  • VNDA $11.00
  • TCMD $30.00
  • AVG Volume (30 Days)
  • VNDA 823.5K
  • TCMD 349.9K
  • Earning Date
  • VNDA 07-29-2024
  • TCMD 08-05-2024
  • Dividend Yield
  • VNDA N/A
  • TCMD N/A
  • EPS Growth
  • VNDA N/A
  • TCMD N/A
  • EPS
  • VNDA N/A
  • TCMD 1.20
  • Revenue
  • VNDA $177,604,000.00
  • TCMD $276,665,000.00
  • Revenue This Year
  • VNDA $2.98
  • TCMD $12.60
  • Revenue Next Year
  • VNDA $19.49
  • TCMD $12.61
  • P/E Ratio
  • VNDA N/A
  • TCMD $10.26
  • Revenue Growth
  • VNDA N/A
  • TCMD 7.38
  • 52 Week Low
  • VNDA $3.30
  • TCMD $9.70
  • 52 Week High
  • VNDA $6.75
  • TCMD $23.33
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 62.74
  • TCMD 60.47
  • Support Level
  • VNDA $5.89
  • TCMD $12.18
  • Resistance Level
  • VNDA $6.33
  • TCMD $12.92
  • Average True Range (ATR)
  • VNDA 0.26
  • TCMD 0.37
  • MACD
  • VNDA 0.06
  • TCMD 0.17
  • Stochastic Oscillator
  • VNDA 97.98
  • TCMD 86.67

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.

About TCMD Tactile Systems Technology Inc.

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

Share on Social Networks: